Healthcare - Biotechnology - NASDAQ - GB
$ 0.682
-38.6 %
$ 3.53 M
Market Cap
-1.1
P/E
BALANCE SHEET
20.6 M
ASSETS
5.26 M
LIABILITIES
24.8 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Aptorum Group Limited
| Current Assets | 2.48 M |
| Cash & Short-Term Investments | 2.01 M |
| Receivables | 70.9 K |
| Other Current Assets | 400 K |
| Non-Current Assets | 18.2 M |
| Long-Term Investments | 16.1 M |
| PP&E | 1.85 M |
| Other Non-Current Assets | 219 K |
| Current Liabilities | 2.1 M |
| Accounts Payable | 0 |
| Short-Term Debt | 125 K |
| Other Current Liabilities | 1.97 M |
| Non-Current Liabilities | 3.16 M |
| Long-Term Debt | 3.16 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 2.0 | 1.9 | 8.1 | 3.5 | 5.2 | 12.0 | 16.2 |
| Short Term Investments | 0 | 0.1 | 0.2 | 28.4 | 1.1 | 1.0 | 2.0 |
| Receivables | 70.9 K | 1.2 | 3.6 | 0.3 | 0.5 | 1.0 | 0.2 |
| Inventory | 0 | 27.7 K | 35.8 K | 39.1 K | 34.2 K | 30.6 K | 1.5 |
| Other Current Assets | 0.3 | 3.7 | 0.7 | 1.4 | 1.3 | 14.5 | 0.3 |
| Total Current Assets | 2.5 | 7.1 | 12.7 | 33.7 | 8.0 | 28.7 | 20.3 |
| PP&E | 1.8 | 3.2 | 4.0 | 5.4 | 7.1 | 4.3 | 0.3 |
| Intangible Assets | 0.1 | 0.8 | 0.9 | 1.0 | 1.3 | 1.4 | 1.5 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 16.1 | 9.7 | 4.2 | 4.1 | 7.1 | 7.1 | 7.4 |
| Other Long Term Assets | 71.8 K | 0.1 | 0.1 | 0.1 | 59.8 K | 0.1 | 2.1 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 20.6 | 20.9 | 21.9 | 44.2 | 24.0 | 45.1 | 31.6 |
| LIABILITIES | |||||||
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 40.1 K | 0 |
| Short Term Debt | 0.1 | 6.3 | 0.2 | 0.5 | 46.6 K | 10.2 | 0.5 |
| Other Current Liabilities | 2.0 | 6.2 | 4.2 | 3.4 | 2.6 | 2.0 | 0.9 |
| Total Current Liabilities | 2.1 | 12.5 | 4.4 | 3.9 | 2.7 | 12.2 | 1.3 |
| Long Term Debt | 3.2 | 0.5 | 23.9 K | 2.2 | 6.4 | 0.1 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 5.3 | 13.0 | 4.4 | 6.1 | 9.1 | 12.3 | 1.3 |
| EQUITY | |||||||
| Common Stock | 53 | 35.7 | 35.6 | 34.0 | 29.0 | 29.0 | 27.9 |
| Retained Earnings | (68.2) | (65.3) | (55.5) | (30.5) | (37.6) | (17.4) | (2.5) |
| Other Accumulative Comprehensive Income/Loss | 10.6 K | 33.8 K | 2.02 K | 53.3 K | 5.55 K | (1.5) | (0.4) |
| Total Equity | 15.4 | 7.8 | 17.5 | 38.2 | 14.9 | 32.7 | 30.2 |
| Total Liabilities and Equity | 20.6 | 20.9 | 21.9 | 44.2 | 24.0 | 45.1 | 31.6 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 4.5 | 0.4 | 3.5 | 3.1 | 2.9 | 2.8 | 3.0 |